KEY CONCEPTS

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
< Go back

GILD – Gilead Sciences Inc

Gilead Sciences, Inc., is a pharmaceutical and biotechnology company focusing on antiviral drugs to treat HIV, hepatitis B, hepatitis C, and influenza, notably producing and commercializing the blockbuster drugs Harvoni and Sovald. Besides, Gilead conducts research to develop a pipeline of new drugs and treatments and it also considers the acquisition of other blockbuster drugs.

Website: gilead.com – Market Cap.: $ 90.2 Billion – Stock symbol: GILD

 

If you want to know more about GILD, click here to review the article written by our investment team.